Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Regeneron
Regeneron
US appeals court revives Regeneron's antitrust lawsuit against Novartis
Yahoo/Reuters
Mon, 03/18/24 - 05:09 pm
Novartis
Regeneron
legal
Eylea
Lucentis
antitrust
Incyte, itching for a piece of Dupixent's market, hits goals in midphase skin disease trial
Fierce Biotech
Mon, 03/11/24 - 11:52 am
Incyte
clinical trials
prurigo nodularis
povorcitinib
Dupixent
Sanofi
Regeneron
Sanofi, Regeneron Secure FDA Priority Review for Dupixent in COPD
BioSpace
Fri, 02/23/24 - 10:43 am
FDA
Sanofi
Regeneron
Dupixent
priority review
COPD
Regeneron Looks to Target Weight Loss Market with Muscle-Preserving Antibodies
BioSpace
Mon, 02/5/24 - 10:20 am
Regeneron
obesity
muscle
drug development
2seventy bio to sell experimental cell therapies, names new CEO
Reuters
Tue, 01/30/24 - 10:23 am
2seventy bio
Regeneron
Abecma
cell therapy
Sanofi, Regeneron Win Dupixent Label Expansion to Treat Eosinophilic Esophagitis
BioSpace
Fri, 01/26/24 - 11:19 am
Regeneron
Sanofi
Dupixent
eosinic esophagitis
pediatric
FDA
Drugmakers explore muscle loss prevention when taking weight loss drugs
Beckers Hospital Review
Tue, 01/23/24 - 11:06 am
weight loss
muscle
Ozempic
Wegovy
Eli Lilly
Regeneron
Trials to watch: CRISPR pipeline accelerates after milestone Casgevy approval
Clinical Trials Arena
Wed, 01/17/24 - 09:30 am
CRISPR
gene editing
clinical trials
Casgevy
Vertex Pharmaceuticals
CRISPR Therapeutics
EdiGene
Shanghai Vitalgen BioPharma
Regeneron
Vor Biopharma
Regeneron hands off certain Libtayo rights in Europe to Medison Pharma
Fierce Pharma
Mon, 01/8/24 - 10:17 pm
Regeneron
Libtayo
Europe
Madison Pharma
JPM24, Day 1: Regeneron's Eylea misses analyst estimates; Moderna touts $6.7B in '23 sales
Fierce Pharma
Mon, 01/8/24 - 11:45 am
JPMHC 2024
Regeneron
Eylea
Eylea HD
Moderna Therapeutics
Regeneron Gains After Eye-Drug Patent Victory Over Viatris
Yahoo/Bloomberg
Sun, 12/31/23 - 11:46 am
Regeneron
Eylea
Viatris
patents
legal
Dupixent for cancer? Researchers test blockbuster med as an immunotherapy-booster
Fierce Biotech
Thu, 12/7/23 - 11:13 pm
Regeneron
Sanofi
Dupixent
cancer
lung cancer
Regeneron touts possible 'best-in-class' myeloma bispecific, but adverse events climb to 100%
Fierce Biotech
Thu, 12/7/23 - 11:52 am
Regeneron
clinical trials
bispecific
Multiple Myeloma
patient deaths
linvoseltamab
Sanofi, Regeneron eye Dupixent label expansion with promising COPD data
Medical Marketing and Media
Tue, 11/28/23 - 10:27 am
Sanofi
Regeneron
Dupixent
clinical trials
COPD
Regeneron stays out of ADC deal fray as in-house scientists tinker
Fierce Biotech
Wed, 11/15/23 - 11:08 am
Regeneron
antibody-drug conjugate
Regeneron touts launch of high-dose Eylea in battle with Roche's Vabysmo
Fierce Pharma
Thu, 11/2/23 - 11:48 am
Regeneron
Eylea
Roche
Vabysmo
Regeneron beats quarterly profit estimates on eczema treatment strength
Reuters
Thu, 11/2/23 - 11:33 am
Regeneron
earnings
Dupixent
Dupixent returns as top Rx, OTC brand for September
Medical Marketing and Media
Tue, 10/17/23 - 09:41 pm
Sanofi
Regeneron
Dupixent
DTC ads
pharma ads
Here's the Best Big Pharma Stock of the Decade so Far (and It's Not Even Close)
Motley Fool
Fri, 10/6/23 - 10:05 am
Eli Lilly
Regeneron
Novo Nordisk
Top Pharma Ad Spenders in August 2023, AbbVie Splurges to Take Top Spots
Xtalks
Sun, 10/1/23 - 01:28 pm
pharma advertising
DTC ads
AbbVie
Skyrizi
Rinvoq
Regeneron
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »